RPL38P1

Across TCGA pan-cancer cohorts, RPL38P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPL38P1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RPL38P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL38P1 expression acts as an unfavorable survival marker, although some lineages such as PRAD show a favorable association.

HNSC, LUAD, and PAAD are the cancer types where RPL38P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	IV	0.229	0.594	.001	57	view →
LUAD	OS	Tertile	All	0.630	0.846	<.001	54	view →
PAAD	OS	Tertile	All	0.376	0.623	.017	36	view →
UCEC	OS	Tertile	III,IV	0.560	0.838	.018	24	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
UVM	DFS	Tertile	All	0.240	0.760	.022	18	view →
SKCM	DFS	Tertile	III,IV	0.272	0.662	.001	18	view →
BLCA	OS	Tertile	III,IV	0.141	0.581	.011	18	view →
STAD	OS	Quartile	II,III,IV	0.554	0.771	.009	16	view →
KIRC	OS	Tertile	All	0.527	0.643	.033	15	view →
THYM	OS	Tertile	All	0.581	0.918	.002	12	view →
BRCA	OS	Tertile	II,III,IV	0.848	0.916	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPL38P1–HNSC (DFS)

Open the HNSC breakdown →